COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis
Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers hyperglycemia. Herein, we interrogated whether and how SARS-CoV-2 causes hyperglycemia by infecting hepatocytes and increasing...
Uložené v:
| Vydané v: | Proceedings of the National Academy of Sciences - PNAS Ročník 120; číslo 21; s. e2217119120 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
23.05.2023
|
| Predmet: | |
| ISSN: | 1091-6490, 1091-6490 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers hyperglycemia. Herein, we interrogated whether and how SARS-CoV-2 causes hyperglycemia by infecting hepatocytes and increasing glucose production. We performed a retrospective cohort study including patients that were admitted at a hospital with suspicion of COVID-19. Clinical and laboratory data were collected from the chart records and daily blood glucose values were analyzed to test the hypothesis on whether COVID-19 was independently associated with hyperglycemia. Blood glucose was collected from a subgroup of nondiabetic patients to assess pancreatic hormones.
liver biopsies were collected to assess the presence of SARS-CoV-2 and its transporters in hepatocytes. In human hepatocytes, we studied the mechanistic bases of SARS-CoV-2 entrance and its gluconeogenic effect. SARS-CoV-2 infection was independently associated with hyperglycemia, regardless of diabetic history and beta cell function. We detected replicating viruses in human hepatocytes from
liver biopsies and in primary hepatocytes. We found that SARS-CoV-2 variants infected human hepatocytes in vitro with different susceptibility. SARS-CoV-2 infection in hepatocytes yields the release of new infectious viral particles, though not causing cell damage. We showed that infected hepatocytes increase glucose production and this is associated with induction of PEPCK activity. Furthermore, our results demonstrate that SARS-CoV-2 entry in hepatocytes occurs partially through ACE2- and GRP78-dependent mechanisms. SARS-CoV-2 infects and replicates in hepatocytes and exerts a PEPCK-dependent gluconeogenic effect in these cells that potentially is a key cause of hyperglycemia in infected patients. |
|---|---|
| AbstractList | Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers hyperglycemia. Herein, we interrogated whether and how SARS-CoV-2 causes hyperglycemia by infecting hepatocytes and increasing glucose production. We performed a retrospective cohort study including patients that were admitted at a hospital with suspicion of COVID-19. Clinical and laboratory data were collected from the chart records and daily blood glucose values were analyzed to test the hypothesis on whether COVID-19 was independently associated with hyperglycemia. Blood glucose was collected from a subgroup of nondiabetic patients to assess pancreatic hormones. Postmortem liver biopsies were collected to assess the presence of SARS-CoV-2 and its transporters in hepatocytes. In human hepatocytes, we studied the mechanistic bases of SARS-CoV-2 entrance and its gluconeogenic effect. SARS-CoV-2 infection was independently associated with hyperglycemia, regardless of diabetic history and beta cell function. We detected replicating viruses in human hepatocytes from postmortem liver biopsies and in primary hepatocytes. We found that SARS-CoV-2 variants infected human hepatocytes in vitro with different susceptibility. SARS-CoV-2 infection in hepatocytes yields the release of new infectious viral particles, though not causing cell damage. We showed that infected hepatocytes increase glucose production and this is associated with induction of PEPCK activity. Furthermore, our results demonstrate that SARS-CoV-2 entry in hepatocytes occurs partially through ACE2- and GRP78-dependent mechanisms. SARS-CoV-2 infects and replicates in hepatocytes and exerts a PEPCK-dependent gluconeogenic effect in these cells that potentially is a key cause of hyperglycemia in infected patients.Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers hyperglycemia. Herein, we interrogated whether and how SARS-CoV-2 causes hyperglycemia by infecting hepatocytes and increasing glucose production. We performed a retrospective cohort study including patients that were admitted at a hospital with suspicion of COVID-19. Clinical and laboratory data were collected from the chart records and daily blood glucose values were analyzed to test the hypothesis on whether COVID-19 was independently associated with hyperglycemia. Blood glucose was collected from a subgroup of nondiabetic patients to assess pancreatic hormones. Postmortem liver biopsies were collected to assess the presence of SARS-CoV-2 and its transporters in hepatocytes. In human hepatocytes, we studied the mechanistic bases of SARS-CoV-2 entrance and its gluconeogenic effect. SARS-CoV-2 infection was independently associated with hyperglycemia, regardless of diabetic history and beta cell function. We detected replicating viruses in human hepatocytes from postmortem liver biopsies and in primary hepatocytes. We found that SARS-CoV-2 variants infected human hepatocytes in vitro with different susceptibility. SARS-CoV-2 infection in hepatocytes yields the release of new infectious viral particles, though not causing cell damage. We showed that infected hepatocytes increase glucose production and this is associated with induction of PEPCK activity. Furthermore, our results demonstrate that SARS-CoV-2 entry in hepatocytes occurs partially through ACE2- and GRP78-dependent mechanisms. SARS-CoV-2 infects and replicates in hepatocytes and exerts a PEPCK-dependent gluconeogenic effect in these cells that potentially is a key cause of hyperglycemia in infected patients. Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2 directly triggers hyperglycemia. Herein, we interrogated whether and how SARS-CoV-2 causes hyperglycemia by infecting hepatocytes and increasing glucose production. We performed a retrospective cohort study including patients that were admitted at a hospital with suspicion of COVID-19. Clinical and laboratory data were collected from the chart records and daily blood glucose values were analyzed to test the hypothesis on whether COVID-19 was independently associated with hyperglycemia. Blood glucose was collected from a subgroup of nondiabetic patients to assess pancreatic hormones. liver biopsies were collected to assess the presence of SARS-CoV-2 and its transporters in hepatocytes. In human hepatocytes, we studied the mechanistic bases of SARS-CoV-2 entrance and its gluconeogenic effect. SARS-CoV-2 infection was independently associated with hyperglycemia, regardless of diabetic history and beta cell function. We detected replicating viruses in human hepatocytes from liver biopsies and in primary hepatocytes. We found that SARS-CoV-2 variants infected human hepatocytes in vitro with different susceptibility. SARS-CoV-2 infection in hepatocytes yields the release of new infectious viral particles, though not causing cell damage. We showed that infected hepatocytes increase glucose production and this is associated with induction of PEPCK activity. Furthermore, our results demonstrate that SARS-CoV-2 entry in hepatocytes occurs partially through ACE2- and GRP78-dependent mechanisms. SARS-CoV-2 infects and replicates in hepatocytes and exerts a PEPCK-dependent gluconeogenic effect in these cells that potentially is a key cause of hyperglycemia in infected patients. |
| Author | Bernardelli, Rafaella S de Oliveira, Renê D R Singh, Youvika Guimarães, Raphael C Gonçalves, Tiago T Mori, Marcelo A Barreto, Ester A Nakaya, Helder I Réa, Rosângela Réa Neto, Álvaro Souza, Gabriela F Proenca-Modena, José L Pereira, Nayara Cunha, Fernando Q Fernandes da Silva, Miguel M Alves, João Manoel Cruz, Amanda S Batah, Sabrina Setembre Martins, Ronaldo Louzada-Junior, Paulo Veras, Flavio P Muraro, Stéfanie P Damasceno, Samara Arruda, Eurico Forato, Julia Lima, Thais M Leiria, Luiz Osório Paiva, Isadora M Fabro, Alexandre Cunha, Thiago M |
| Author_xml | – sequence: 1 givenname: Ester A surname: Barreto fullname: Barreto, Ester A organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 2 givenname: Amanda S orcidid: 0000-0001-6072-1721 surname: Cruz fullname: Cruz, Amanda S organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 3 givenname: Flavio P orcidid: 0000-0002-6222-4064 surname: Veras fullname: Veras, Flavio P organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 4 givenname: Ronaldo orcidid: 0000-0002-8902-5962 surname: Martins fullname: Martins, Ronaldo organization: Department of Cell Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 5 givenname: Rafaella S surname: Bernardelli fullname: Bernardelli, Rafaella S organization: Federal University of Paraná, Center for Study and Research in Intensive Care Medicine, Curitiba 82530-200, Brazil – sequence: 6 givenname: Isadora M orcidid: 0000-0002-2741-150X surname: Paiva fullname: Paiva, Isadora M organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 7 givenname: Thais M surname: Lima fullname: Lima, Thais M organization: Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 8 givenname: Youvika orcidid: 0000-0002-4274-4484 surname: Singh fullname: Singh, Youvika organization: Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil – sequence: 9 givenname: Raphael C surname: Guimarães fullname: Guimarães, Raphael C organization: Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil – sequence: 10 givenname: Samara orcidid: 0000-0002-0215-4420 surname: Damasceno fullname: Damasceno, Samara organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 11 givenname: Nayara surname: Pereira fullname: Pereira, Nayara organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 12 givenname: João Manoel surname: Alves fullname: Alves, João Manoel organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 13 givenname: Tiago T orcidid: 0000-0002-7503-6062 surname: Gonçalves fullname: Gonçalves, Tiago T organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 14 givenname: Julia orcidid: 0000-0002-6247-9657 surname: Forato fullname: Forato, Julia organization: Department of Genetics, Microbiology and Immunology, Laboratory of Emerging Viruses, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil – sequence: 15 givenname: Stéfanie P orcidid: 0000-0002-5105-6659 surname: Muraro fullname: Muraro, Stéfanie P organization: Department of Genetics, Microbiology and Immunology, Laboratory of Emerging Viruses, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil – sequence: 16 givenname: Gabriela F orcidid: 0000-0001-7285-0790 surname: Souza fullname: Souza, Gabriela F organization: Department of Genetics, Microbiology and Immunology, Laboratory of Emerging Viruses, Institute of Biology, University of Campinas, Campinas 13083-970, Brazil – sequence: 17 givenname: Sabrina Setembre surname: Batah fullname: Batah, Sabrina Setembre organization: Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 18 givenname: José L orcidid: 0000-0002-4996-3153 surname: Proenca-Modena fullname: Proenca-Modena, José L organization: Experimental Medicine Research, Cluster University of Campinas, Campinas 13083-970, Brazil – sequence: 19 givenname: Marcelo A orcidid: 0000-0001-7112-5263 surname: Mori fullname: Mori, Marcelo A organization: Obesity and Comorbidities Research Center, University of Campinas, Campinas 13083-864, Brazil – sequence: 20 givenname: Fernando Q surname: Cunha fullname: Cunha, Fernando Q organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 21 givenname: Paulo orcidid: 0000-0003-2585-3870 surname: Louzada-Junior fullname: Louzada-Junior, Paulo organization: Divisions of Clinical Immunology, Emergency, Infectious Diseases, and Intensive Care Unit, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 22 givenname: Thiago M surname: Cunha fullname: Cunha, Thiago M organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 23 givenname: Helder I orcidid: 0000-0001-5297-9108 surname: Nakaya fullname: Nakaya, Helder I organization: Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil – sequence: 24 givenname: Alexandre surname: Fabro fullname: Fabro, Alexandre organization: Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 25 givenname: Renê D R surname: de Oliveira fullname: de Oliveira, Renê D R organization: Divisions of Clinical Immunology, Emergency, Infectious Diseases, and Intensive Care Unit, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 26 givenname: Eurico orcidid: 0000-0002-0978-410X surname: Arruda fullname: Arruda, Eurico organization: Department of Cell Biology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil – sequence: 27 givenname: Rosângela surname: Réa fullname: Réa, Rosângela organization: Hospital de Clínicas da Universidade Federal do Paraná, Curitiba 80060-900, Brazil – sequence: 28 givenname: Álvaro orcidid: 0000-0001-5524-0907 surname: Réa Neto fullname: Réa Neto, Álvaro organization: Hospital de Clínicas da Universidade Federal do Paraná, Curitiba 80060-900, Brazil – sequence: 29 givenname: Miguel M surname: Fernandes da Silva fullname: Fernandes da Silva, Miguel M organization: Hospital de Clínicas da Universidade Federal do Paraná, Curitiba 80060-900, Brazil – sequence: 30 givenname: Luiz Osório surname: Leiria fullname: Leiria, Luiz Osório organization: Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, Brazil |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37186819$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtPwzAQhC1URB9w5oZy5JLidZzGPqLyqlSpF-Aa2c46NcqL2BHKvyeCInHalebb2dEsyaxpGyTkGugaaJbcdY3ya8YgA5DA6BlZAJUQb7iks3_7nCy9_6CUylTQCzJPMhAbAXJB6u3hffcQg4x7rFTAIjqOHfZlNRqsnYqcj5T3rXE_2pcLx8g1Fk1wbRO1Njpip0JrxoAT2BSRD64eJqOTXFaDmRK3JTbonb8k51ZVHq9Oc0Xenh5fty_x_vC8297vY8NTEWLGreapBYtFMv2ylFGpbSpTnimZiIRRoYvEaJMwSQGs1hmmTNANcs1VxtmK3P76dn37OaAPee28wapSU5bB50wAT6dbmU3ozQkddI1F3vWuVv2Y_1XEvgF8HmxF |
| CitedBy_id | crossref_primary_10_1016_j_abst_2024_12_001 crossref_primary_10_1016_j_mib_2024_102455 crossref_primary_10_1016_j_tem_2024_05_006 crossref_primary_10_3390_v16111769 crossref_primary_10_1097_MD_0000000000039427 crossref_primary_10_3390_ijms26010364 crossref_primary_10_1016_j_molmed_2023_06_001 crossref_primary_10_2174_0113816128300162240322075423 crossref_primary_10_3390_biomedicines13061482 crossref_primary_10_1002_jmv_70156 crossref_primary_10_3390_ijms25189977 crossref_primary_10_1210_endrev_bnad032 crossref_primary_10_1038_s41467_024_50339_4 crossref_primary_10_3390_pathophysiology31020016 crossref_primary_10_7759_cureus_54249 crossref_primary_10_1038_s41392_024_01796_2 crossref_primary_10_3390_pathophysiology32030039 crossref_primary_10_1371_journal_ppat_1012156 crossref_primary_10_3928_19382359_20240502_07 crossref_primary_10_1016_j_diabres_2024_111926 crossref_primary_10_1111_jcmm_70581 crossref_primary_10_1097_HC9_0000000000000290 crossref_primary_10_1007_s10930_024_10191_3 crossref_primary_10_1128_mbio_00634_25 crossref_primary_10_3390_microorganisms13061390 crossref_primary_10_1002_jgh3_13039 crossref_primary_10_3390_cells13090769 crossref_primary_10_3389_fcimb_2024_1407261 crossref_primary_10_1038_s44321_024_00188_x crossref_primary_10_3389_fimmu_2025_1582783 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1073/pnas.2217119120 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Sciences (General) |
| EISSN | 1091-6490 |
| ExternalDocumentID | 37186819 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -DZ -~X .55 0R~ 123 29P 2FS 2WC 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE ABOCM ABPLY ABPPZ ABTLG ABZEH ACGOD ACIWK ACNCT ACPRK AENEX AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BKOMP CGR CS3 CUY CVF D0L DIK DU5 E3Z EBS ECM EIF F5P FRP GX1 H13 HH5 HYE JENOY JLS JSG KQ8 L7B LU7 N9A NPM N~3 O9- OK1 PNE PQQKQ R.V RHI RNA RNS RPM RXW SJN TAE TN5 UKR W8F WH7 WOQ WOW X7M XSW Y6R YBH YKV YSK ZCA ~02 ~KM 7X8 |
| ID | FETCH-LOGICAL-c458t-24fb45f1fed3fecf0209bf59547a9383208bd3cbc329011fbb7e52806e4b4a742 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 34 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001031481900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1091-6490 |
| IngestDate | Sun Nov 09 09:31:13 EST 2025 Mon Jul 21 05:48:30 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 21 |
| Keywords | liver SARS-CoV-2 glucose |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c458t-24fb45f1fed3fecf0209bf59547a9383208bd3cbc329011fbb7e52806e4b4a742 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-5524-0907 0000-0002-7503-6062 0000-0002-0978-410X 0000-0001-6072-1721 0000-0002-6247-9657 0000-0001-7112-5263 0000-0001-7285-0790 0000-0003-2585-3870 0000-0002-2741-150X 0000-0002-4996-3153 0000-0002-5105-6659 0000-0001-5297-9108 0000-0002-8902-5962 0000-0002-6222-4064 0000-0002-4274-4484 0000-0002-0215-4420 |
| OpenAccessLink | https://www.pnas.org/doi/10.1073/pnas.2217119120 |
| PMID | 37186819 |
| PQID | 2814529097 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2814529097 pubmed_primary_37186819 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-23 |
| PublicationDateYYYYMMDD | 2023-05-23 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-23 day: 23 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
| PublicationTitleAlternate | Proc Natl Acad Sci U S A |
| PublicationYear | 2023 |
| SSID | ssj0009580 |
| Score | 2.5675004 |
| Snippet | Occurrence of hyperglycemia upon infection is associated with worse clinical outcome in COVID-19 patients. However, it is still unknown whether SARS-CoV-2... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | e2217119120 |
| SubjectTerms | Blood Glucose COVID-19 - complications Gluconeogenesis Glucose Hepatocytes Humans Hyperglycemia - complications Retrospective Studies SARS-CoV-2 |
| Title | COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37186819 https://www.proquest.com/docview/2814529097 |
| Volume | 120 |
| WOSCitedRecordID | wos001031481900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JTwMhFCZuBy_u-xJMPOgBnRmgwMkYl2ii1YOa3hoYoDax09qpJv33PmZo9GJi4mUuZIDw4C18j-8hdMiENDWqK3JOmNWcSKk8EdyCQbSJFtX7ipc70WzKVks9xgu3MqZVTnRipahtPw935KeZTANGmChxNngnoWpUQFdjCY1pNEvBlQkHU7TkD9JdWbMRqJQ0mEom1D6Cng4KXZ5k4I8HgrMs-d2_rOzM9eJ_Z7iEFqKHic_rLbGMplyxgpbjGS7xUSSaPl5FvYuHl9tLkipSvWhxFr9CVDrsvI1z1-tq3C2xjtKDtnBjiye5WwXue_wKpmzUz8fgrWJdWAzaohergYXmKhu-cP1OUKfdcg09X189XdyQWH6B5IzLEcmYN4z71DtLoW8PjqUynivOhFYQ2GaJNJbmJqcBi029McLxANQ6ZhjIOFtHMwUMs4mwoYlzjIkEoj0GIZtsOE-t1ob7BnTZ2EIHkyVtw_YOmIWG-X2U7e9F3UIbtVzag5qHo01F4PpP1fYf_t5B86FQfMD9M7qLZj0cbreH5vLPUbcc7lf7Br7Nx_svMPnN-g |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID-19-related+hyperglycemia+is+associated+with+infection+of+hepatocytes+and+stimulation+of+gluconeogenesis&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Barreto%2C+Ester+A&rft.au=Cruz%2C+Amanda+S&rft.au=Veras%2C+Flavio+P&rft.au=Martins%2C+Ronaldo&rft.date=2023-05-23&rft.eissn=1091-6490&rft.volume=120&rft.issue=21&rft.spage=e2217119120&rft_id=info:doi/10.1073%2Fpnas.2217119120&rft_id=info%3Apmid%2F37186819&rft_id=info%3Apmid%2F37186819&rft.externalDocID=37186819 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1091-6490&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1091-6490&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1091-6490&client=summon |